ACP awarded grant to help patients recognize warning signs, prevent stroke

ACP received a $212,000 grant sponsorship to develop a program to help patients recognize the signs and symptoms of nonvalvular atrial fibrillation (NVAF).

The support of the “Stopping Stroke Through Engaged Patients” (STEP) program came from the Bristol-Myers Squibb and Pfizer alliance. Under an advisory committee of clinical experts and patient advocate representatives with support from ACP's Center for Patient Partnership in Healthcare (CPPH), the STEP program will develop a comprehensive toolkit that includes a self-management guidebook, worksheets to engage and empower patients, and a video.

Stroke is a leading cause of death in the United States, and given the aging U.S. population, the number of NVAF cases could reach 12.1 million by 2030. More information about ACP's STEP program is online.